Literature DB >> 12718897

Progress towards a vaccine for Huntington's disease.

Ruth Luthi-Carter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12718897     DOI： 10.1016/s1525-0016(03)00107-2

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  6 in total

Review 1.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

Review 2.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

3.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

4.  Autoantibodies to alpha-synuclein in inherited Parkinson's disease.

Authors:  Katerina K Papachroni; Natalia Ninkina; Angeliki Papapanagiotou; Georgios M Hadjigeorgiou; Georgia Xiromerisiou; Alexandros Papadimitriou; Anastasios Kalofoutis; Vladimir L Buchman
Journal:  J Neurochem       Date:  2007-05       Impact factor: 5.372

5.  Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Michael Mante; Harald Weninger; Christina Patrick; Anthony Adame; Sabine Schmidhuber; Radmila Santic; Achim Schneeberger; Walter Schmidt; Frank Mattner; Eliezer Masliah
Journal:  Mol Neurodegener       Date:  2015-03-19       Impact factor: 14.195

Review 6.  Promises and pitfalls of immune-based strategies for Huntington's disease.

Authors:  Gabriela Delevati Colpo; Erin Furr Stimming; Natalia Pessoa Rocha; Antonio Lucio Teixeira
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.